HOLDEN LOWELL THOMAS - Insider Non-Derivative Transactions at Nascent Biotech Inc. (NBIO) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jun 30, 2024, HOLDEN LOWELL THOMAS's relationship to Nascent Biotech Inc. (NBIO) is Director,Officer (CFO), and currently has 10,005,477 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other NBIO insiders.

Data Source: SEC.
HOLDEN LOWELL THOMAS - Insider Non-Derivative Transactions of NBIO Common Stock
HOLDEN LOWELL THOMAS - Insider Non-Derivative Transactions at NBIO
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jul 1, 2024 J -- (Common stock) 96000 0.09 10005477
Apr 1, 2024 J -- (Common Stock) 112500 0.18 9909477
Dec 30, 2023 J -- (Common Stock) 119650 0.17 9796977
Sep 30, 2023 J -- (Common Stock) 1386300 0.13 9677327
Jun 30, 2023 G -- (Common Stock) 700000 0.05 8291027
Jun 8, 2023 P -- (Common stock) 130000 0.04 8409277
Apr 1, 2023 J -- (Common stock) 581000 0.06 8279277
Feb 10, 2023 G -- (Common stock) 700000 0.12 7798277
Jan 28, 2023 P -- (Common Stock) 20000 0.14 8418277
Dec 31, 2022 Acquisition -- (Common Stock) 231000 0.2 8398277